Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
PatientBase is the premier epidemiology database that provides robust coverage of more than 120 disease indications and more than 2000 patient populations... Learn More
Join us live on June 25, 2013... Learn More
View Webinar schedule and archive
See which reports have been searched on the most.
Global Biosimilars Pathways and Clinical Development Activity. Where Are the Biosimilars Hotspots?
This new infographic from BioTrends Research Group’s Biosimilars Advisory Service: Global Pipelines, Regulatory Pathways and Key Stakeholder Perspectives highlights global market activity for the dynamic and complex biosimilars industry.
June 13, 2013
Turkey’s Non-Small-Cell Lung Cancer Drug Market Projected to Grow at 7 Percent Annually Through 2017
June 12, 2013
Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
June 10, 2013
Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
What Type and Magnitude of Clinical Improvements Over
Current Mainstays of Treatment Would Make Neurologists and... Read More
Colorectal Cancer (Second-Line Metastatic)
As the Second-Line Treatment Setting for Colorectal
Cancer Becomes More Crowded, How Will Oncologists and Payers... Read More
The Approaching Cliff: How Will the Availability of Generic Antiretrovirals Impact the EU5 Prescribing and Reimbursement Landscape for Current and Emerging Brands in HIV?
This report explores
the dynamics that affect sales of current and emerging antiretroviral (ARV)
therapies used for... Read More